English
I-Olaparib Intermediate CAS 763114-26-7 Purity ≥98.5% Isithombe Esifakiwe Sefekthri
  • I-Olaparib Intermediate CAS 763114-26-7 Purity ≥98.5% Factory

I-Olaparib Intermediate CAS 763114-26-7 Purity ≥98.5% Factory

Incazelo emfushane:

Igama Lekhemikhali: 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid

I-CAS: 763114-26-7

Ubumsulwa: ≥98.5%

Ukubukeka: Impushana Ephuzi ukuya Emhlophe

I-Olaparib emaphakathi (CAS 763113-22-0) yokwelashwa kwe-germline BRCA-mediated advanced ovarian cancer

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Ukuhlanzeka Okuphezulu, Ukukhiqizwa Kwezohwebo
I-Olaparib kanye Nezixhumanisi Ezihlobene:
I-Olaparib CAS 763113-22-0
I-2-Fluoro-5-Formylbenzonitrile CAS 218301-22-5
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid CAS 763114-26-7
1-(Cyclopropylcarbonyl)piperazine Hydrochloride CAS 1021298-67-8
I-3-Oxo-1,3-Dihydroisobenzofuran-1-Ylphosphonic Acid CAS 61260-15-9

Chemical Properties:

Igama Lekhemikhali 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
Omqondofana 2-Fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoic acid
Inombolo ye-CAS 763114-26-7
Inombolo yeCAT I-RF-PI450
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula I-C16H11FN2O3
Isisindo samangqamuzana 298.27
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Ephuzi ukuya Emhlophe
Isivivinyo ≥98.5%
Umswakama (KF) ≤0.50%
Ukungcola Okuphelele ≤1.5%
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate of Olaparib (CAS: 763113-22-0)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, I-Cardboard Drum, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid (CAS: 763114-26-7) iyindawo ephakathi esetshenziswa ekuhlanganiseni kwe-Olaparib (CAS: 763113-22) -0).I-Olaparib, imakethwa yi-AstraZeneca ngaphansi kwegama lomkhiqizo i-Lynparza, yavunywa e-USA ngoDisemba 2014 njengendlela yokwelapha ehlosiwe, ene-ejenti eyodwa yokwelapha umdlavuza we-ovarian othuthukisiwe we-BRCA-mediated advanced ovarian. , isebenza njenge-poly ADP ribose polymerase inhibitor futhi igunyazwe ngokukhethekile ezigulini ezithole ukwelashwa okuthathu noma ngaphezulu kwe-chemotherapy.Ezivivinyweni zomtholampilo, isidakamizwa sandise ukusinda kokungaqhubeki isikhathi eside ezigulini ezinomdlavuza we-serous ovarian ophindelelayo ozwela i-platinum.I-Olaparib nayo okwamanje isezigabeni ezehlukene zophenyo ukuze zelashwe umdlavuza webele, wesisu, wendlala yesinye, we-pancreatic kanye nowokungewona omncane wamaphaphu.

Bhala umyalezo wakho lapha futhi usithumelele wona